EPIX ESSA Pharma: Price-to-Projected Revenue Ratio

Corporate company logo of ESSA Pharma (EPIX)

ESSA Pharma Inc. (EPIX) leverages the high scalability of the pharmaceutical business, where patenting new drugs guarantees global profits. Pipeline diversification through receptor modulators mitigates strategic risks. High testing costs and FDA requirements create an insurmountable barrier to entry for competitors. The forward P/S trend reflects the issuer's current maturity dynamics, with the metric currently standing at .

EPIX ESSA Pharma: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for essapharma.com (EPIX)

- current price and projected stock value:
Stock Price ESSA Pharma|EPIX - Average Forecast Price
- company stock capitalization data:
Market Value ESSA Pharma|EPIX - Company Buyout Price
- book value of equity indicators:
Net Assets per Single Share ESSA Pharma|EPIX - Book Valuation of Business|Market Capitalization to Book Value Ratio essapharma.com|EPIX - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio ESSA Pharma Inc.|EPIX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity ESSA Pharma|EPIX - Company Aggregate Indebtedness|Debts to Book Capitalization ESSA Pharma|EPIX - Company Long-Term Loans and Borrowings|Company Short-Term Debts ESSA Pharma|Quick Liquidity essapharma.com
- business earnings and investment ratios data:
EPIX - Final Profit|Expected Profit ESSA Pharma Inc.|EPIX - Price to Earnings Ratio|Forward P/E Multiple ESSA Pharma|EPIX - PEG Multiple|Enterprise Value to EBITDA Ratio ESSA Pharma|EPIX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ESSA Pharma|EPIX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months essapharma.com|EPIX - Earnings per share growth this year|Earnings growth forecast for next year ESSA Pharma Inc.
- sales volume and revenue indicators:
EPIX - Company Sales|Company Future Sales Volume ESSA Pharma|EPIX - Price-to-Revenue Coefficient|Forward P/S Multiple ESSA Pharma
Fundamental valuation:ESSA Pharma Inc EPIX
Manufactured products of ESSA Pharma

Forward P/S measures the ratio of current market capitalization to expected revenue, allowing for an assessment of the premium paid for an asset's future cash flows. For ESSA Pharma Inc. (EPIX), which is developing targeted oncology therapies through strategic alliances, the projected P/S value serves as an indicator of market expectations regarding patent commercialization, helping investors determine a safe entry point when evaluating the potential of bioengineering developments.

Key competitors

Forward P/S Multiple MRUS (Merus)|Immutep Ltd (IMMP) - Market Cap to Future Revenue Ratio|ANIX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Atossa Pharma ATOS|contexttherapeutics.com (CNTX) - Price-to-Projected Revenue Ratio|MRSN - Market Cap to Expected Sales Ratio|BCTX (BriaCell) - Forward P/S Multiple|Forward P/S Multiple QT Imaging Holdings